- Trials with a EudraCT protocol (17)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
17 result(s) found for: Foveal avascular zone.
Displaying page 1 of 1.
EudraCT Number: 2005-001722-92 | Sponsor Protocol Number: 1 | Start Date*: 2005-10-12 |
Sponsor Name:The Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery | ||
Full Title: Systemic Bevacizumab (Avastin®) Therapy for Exudative Neovascular Age-Related Macular Degeneration (BEAT-AMD-Study) | ||
Medical condition: Age related macular degeneration (AMD) patients with fibrovascular pigment epithelium detachment (PED), subfoveal choroidal neovascularisations (CNV) extending under the geometric center of the fov... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-007232-18 | Sponsor Protocol Number: CRFB002AHU04T | Start Date*: 2009-03-19 | |||||||||||
Sponsor Name:University of Szeged, Medical and Pharmaceutical Center, Department of Ophthalmology [...] | |||||||||||||
Full Title: Comparison of the effect of intravitreal ranibizumab injections compared to macular grid-pattern laser therapy for the symptomatic treatment of diabetic macular edema (a randomized, controlled, pha... | |||||||||||||
Medical condition: Diabetic Macular Edema | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017540-13 | Sponsor Protocol Number: | Start Date*: 2010-07-27 | |||||||||||
Sponsor Name:Clinical Trials and Research Governance | |||||||||||||
Full Title: A Phase IV Open-Labelled Prospective Pilot Study of Intravitreal Macugen (pegaptanib) for Ischaemic Diabetic Macular Oedema (MIDME study) | |||||||||||||
Medical condition: Ischaemic diabetic macular oedema. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005945-39 | Sponsor Protocol Number: HLS03/2007 | Start Date*: 2008-01-30 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: Phase II open label study of Pegaptanib sodium on patients with subfoveal choroidal neovascularization caused by pathologic myopia. | |||||||||||||
Medical condition: Patients with choroidal neovascularization secondary to pathologic myopia. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002977-33 | Sponsor Protocol Number: Luc01AKSI | Start Date*: 2006-06-22 |
Sponsor Name:University Eye Hospital | ||
Full Title: Safety and efficacy of intravitreal injections of ranibizumab/Lucentis in combination with verteporfin photodynamic therapy (PDT) in patients with choroidal neovascularisation (CNV) secondary to ag... | ||
Medical condition: Age related macular degeneration (AMD) is the leading cause of blindness in individuals older than 50 years in the developed world. Eighty to ninety percent of rapid and severe vision loss due to A... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-006290-90 | Sponsor Protocol Number: AU-06102G | Start Date*: 2008-10-10 | |||||||||||
Sponsor Name:Society (Institute) for clinical research | |||||||||||||
Full Title: Subretinal Macugen for neovascular age-related macular degeneration (SUMANA) | |||||||||||||
Medical condition: Neovascular (exudative) age-related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007476-19 | Sponsor Protocol Number: OP/2008/2980 | Start Date*: 2009-09-24 |
Sponsor Name:University Hospitals Bristol NHS Trust | ||
Full Title: A prospective case series of Ranibizumab for the treatment of inflammatory and idiopathic choroidal neovascular membranes. | ||
Medical condition: idiopathic and inflammatory choroidal neovascular membranes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-003304-20 | Sponsor Protocol Number: OKHN1006 | Start Date*: 2012-07-02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Moorfields Eye Hospital NHS Foundation Trust | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Randomised Controlled Trial of Intravitreal therapy with Avastin compared to Observation in Patients with Diabetic Ischaemic Macular Oedema ‘The DIME study’ | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Ischaemic Diabetic Macular Oedema | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-000379-41 | Sponsor Protocol Number: RLBUHT3407 | Start Date*: 2007-05-22 | |||||||||||
Sponsor Name:Royal Liverpool & Broadgreen University hospital | |||||||||||||
Full Title: Liverpool Avastin Dose Response and Retreatment Study | |||||||||||||
Medical condition: Exudative senile macular degeneration of the retina | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000847-89 | Sponsor Protocol Number: BELS1001 | Start Date*: 2007-06-27 | |||||||||||
Sponsor Name:Moorfields Eye Hospital NHS Foundation Trust | |||||||||||||
Full Title: Full Title of Study: Diabetic macular oedema: a prospective randomised trial of management with intravitreal bevacizumab (Avastin) versus conventional laser therapy | |||||||||||||
Medical condition: Diabetic macular oedema | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006131-53 | Sponsor Protocol Number: AU-06104G | Start Date*: 2007-08-02 | |||||||||||
Sponsor Name:Society (institute) for clinical research | |||||||||||||
Full Title: Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study | |||||||||||||
Medical condition: Macular edema secondary to branch retinal vein occlusion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001869-41 | Sponsor Protocol Number: OKHN1005 | Start Date*: 2011-08-24 | ||||||||||||||||
Sponsor Name:Moorfields Eye Hospital NHS Foundation Trust | ||||||||||||||||||
Full Title: An exploratory study of ranibizumab (Lucentis) for treatment of uveitic patients with refractory cystoid macular oedema. 'The LIMO study' | ||||||||||||||||||
Medical condition: Uveitic Macular Oedema | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-003661-17 | Sponsor Protocol Number: SS01 | Start Date*: 2012-11-09 | |||||||||||
Sponsor Name:Moorfields Eye Hospital NHS Foundation Trust | |||||||||||||
Full Title: A Multicentre Prospective Open-label Randomised Clinical Trial Comparing the Efficacy of Fixed versus PRN dosing of 700 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) in patie... | |||||||||||||
Medical condition: Diabetic macular oedema | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001235-30 | Sponsor Protocol Number: MSI-1256F-302 | Start Date*: 2005-10-26 |
Sponsor Name:Genaera Corporation | ||
Full Title: A Phase 3 Multicenter, Randomized, Double-Masked, Controlled Study of Squalamine Lactate (MSI-1256F) for Injection for the Treatment of Subfoveal Choroidal Neovascularization Associated with Age-Re... | ||
Medical condition: Subfoveal Choroidal Neovascularization Associated with Age-Related Macular Degeneration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023900-29 | Sponsor Protocol Number: MAF-AGN-OPH-RET-004 | Start Date*: 2011-08-23 | ||||||||||||||||
Sponsor Name:Allergan Pharmaceuticals Ireland | ||||||||||||||||||
Full Title: A 12-Month, Multicentre, Randomised, Parallel Group Study to Compare the Efficacy and Safety of Ozurdex® Versus Lucentis® in Patients with Branch Retinal Vein Occlusion | ||||||||||||||||||
Medical condition: Macula oedema secondary to branch retinal vein occlusion | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) DE (Completed) ES (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-000243-24 | Sponsor Protocol Number: MD7114987 | Start Date*: 2011-06-07 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd. | |||||||||||||
Full Title: An open-label, phase 2a study to evaluate pazopanib eye drops administered for 12 weeks to patients with neovascular agerelated macular degeneration | |||||||||||||
Medical condition: Age-related macular degeneration (AMD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000031-27 | Sponsor Protocol Number: | Start Date*: 2013-03-20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Moorfields Eye Hospital | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Intravitreal Ranibizumab (Lucentis) Therapy in Patients with Diabetic Ischaemic Macular Oedema (DIME) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Ischaemic Diabetic Macular Oedema | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
